STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
71
13F, latest reported quarter
What the filings say about GEMI
Insiders, 180 days
-$128.7K net sold
1 seller · 33% of sales under a 10b5-1 plan
Activist stakes (13D), 180 days
1 filing
Largest: 65.1% of the class
Gemini Space Station insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Gemini Space Station, Inc. insiders sold a net $128.7K of stock across 7 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jul 2, 2026.
The trade is 4.2% of the 187,923 shares held after it.
No other insider sold within 30 days.
71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Interim CFO Stojanovic Danijela sold about $32.2K of GEMI under a 10b5-1 plan on Aug 20, 2026; 71 funds added in the latest 13F quarter.
No insider has filed to sell. Watch this after a run-up.
GEMI mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Bitwise Bitcoin Standard Corporations ETF
$250.8K position · as of 2026-06-30
1.7%
Fidelity Crypto Industry and Digital Payments ETF
$1.8M position · as of 2026-06-30
0.7%
Inception Portfolio
$1.2M position · as of 2026-06-30
0.4%
Global X Blockchain ETF
$1.2M position · as of 2026-05-31
0.3%
EQ/Morgan Stanley Small Cap Growth Portfolio
$927.5K position · as of 2026-06-30
0.2%
iShares Blockchain and Tech ETF
$66.0K position · as of 2026-06-30
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows a net $128.7K sold by insiders over 180 days, 71 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$206.7M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM GEMI
FY Dec 2025
$179.6M
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
$45.5M
Mar 2026
$50.3M
Dec 2025
$60.3M
Sep 2025
$50.6M
Jun 2025
$33.3M
Mar 2025
$35.3M
Dec 2024
$43.3M
Sep 2024
$24.5M
At each fiscal year end
Single quarter
Net margin, TTM
-250.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM GEMI
FY Dec 2025
-324.6%
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
-236.9%
Mar 2026
-216.8%
Dec 2025
-233.4%
Sep 2025
-315.1%
Jun 2025
-400.2%
Mar 2025
-422.6%
Dec 2024
-62.3%
Sep 2024
-367.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$307.2M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM GEMI
FY Dec 2025
-$220.1M
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
-$51.5M
Mar 2026
-$54.6M
Dec 2025
-$138.4M
Sep 2025
-$62.8M
Jun 2025
-$348.0K
Mar 2025
-$18.6M
Dec 2024
-$5.4M
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term debt only, 2025-12-31 (6 months older than the period end); equity 2026-06-30
Debt to equity GEMI
FY Dec 2025
0.00x
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt GEMI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity GEMI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-34.4%
TTM net income over ending balance 2026-06-30
Return on assets GEMI
FY Dec 2025
-34.3%
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
-34.4%
Mar 2026
-35.6%
Dec 2025
-34.3%
Sep 2025
-20.1%
Jun 2025
-25.1%
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital GEMI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-83.9%
operating income (EBIT proxy) over ending balance 2026-06-30 minus current liabilities
Return on capital employed GEMI
FY Dec 2025
-85.7%
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
-83.9%
Mar 2026
-82.5%
Dec 2025
-85.7%
Sep 2025
-39.0%
Jun 2025
-79.3%
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
0.20x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing GEMI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
0.28x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value GEMI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield GEMI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing GEMI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
GEMI ranks highest on financial health (99th percentile) and growth (68th), and lowest on risk and compliance (3rd), among Financial Services peers.
Profitability
25
Inputs
Return on equityaverage equity is zero or negative
Return on assets-34.4% · 29 pct, sector of 266
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-83.9% · 21 pct, sector of 88
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 181
Cash flow to debtno debt to cover
Growth
68
Inputs
Revenue growth, YoY+26.3% · 68 pct, sector of 245
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
33
Inputs
Net Form 4 buying (codes P and S), 180d-$97K · 66 pct, sector of 161
Insider buyers, 180d0 · 0 pct, sector of 165
Institutional and government
52
Inputs
Funds adding, latest quarter71 · 52 pct, sector of 278
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
3
Inputs
Short interest, % of float+26.4% · 3 pct, sector of 390
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
GEMI filings, in plain words
Are Gemini Space Station insiders buying or selling GEMI?
In the 180 days to 2026-10-27, Gemini Space Station insiders were net sellers, a net $128.7K across purchases and sales reported on Form 4, by 1 seller.
Read the full summary
In the 180 days to 2026-10-27, Gemini Space Station insiders were net sellers of GEMI, a net $128.7K across purchases and sales reported on Form 4 by 1 seller. 33% of the 3 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. 1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 65.1% of the class. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.